Is a testosterone level of 212 ng/dL in a male concerning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, a testosterone level of 212 ng/dL in a male is concerning and warrants further evaluation and likely treatment if accompanied by symptoms.

A testosterone level of 212 ng/dL falls well below the diagnostic threshold of 300 ng/dL used to define testosterone deficiency, and this level should prompt immediate clinical action. 1

Why This Level Is Concerning

This testosterone value is significantly low by any standard:

  • Below diagnostic threshold: The Endocrine Society and AUA guidelines consistently define testosterone deficiency as total testosterone <300 ng/dL 2, 1, 3
  • Associated with increased mortality: Research demonstrates that testosterone levels below 250 ng/dL (8.7 nmol/L) are associated with more than doubled all-cause mortality risk (HR 2.24-2.32), including increased cardiovascular death and cancer mortality 4
  • Age-specific concern: Even for older men in their 70s, the lower limit of normal is around 156 ng/dL at the 2.5th percentile, making 212 ng/dL borderline low even in advanced age 5. For younger men (20-44 years), age-specific cutoffs range from 350-413 ng/dL, making 212 ng/dL markedly abnormal 6

Immediate Next Steps

Confirm the diagnosis with a second early morning testosterone measurement before initiating treatment, as guidelines require two separate low values 1, 3. However, given how low this value is (212 ng/dL), the second test will very likely also be low.

Diagnostic Algorithm:

  1. Repeat morning testosterone (collected within 4 hours of awakening, same laboratory if possible)
  2. Measure LH and FSH to distinguish primary (testicular) from secondary (pituitary-hypothalamic) hypogonadism 2
  3. Assess for symptoms: reduced libido, erectile dysfunction, fatigue, reduced muscle mass, depressed mood, decreased physical performance 1, 3

Additional workup based on LH/FSH results:

If LH/FSH are low or normal (secondary hypogonadism):

  • Check prolactin and iron saturation
  • Consider pituitary MRI if testosterone <150 ng/dL or if symptoms suggest pituitary mass effect 2
  • Evaluate for reversible causes: obesity, medications (opioids, corticosteroids), sleep apnea, chronic illness 2

If LH/FSH are elevated (primary hypogonadism):

  • Consider karyotype to exclude Klinefelter syndrome 2

Treatment Considerations

If symptoms are present and the second testosterone confirms deficiency, testosterone therapy is indicated 2, 3. The goal is to raise testosterone into the mid-normal range (450-600 ng/dL) 3, 7.

Common Pitfalls to Avoid:

  • Don't test during acute illness - testosterone can be transiently suppressed 2
  • Don't rely on afternoon samples - testosterone has diurnal variation with peak levels in early morning 1
  • Don't ignore free testosterone in older men - elevated SHBG with aging can mask true androgen deficiency; 17.2% of ED patients have normal total but low free testosterone, especially those over 60 8
  • Don't assume it's just aging - even in men over 80, only 21.4% have testosterone <275 ng/dL 9, so 212 ng/dL represents pathology requiring evaluation

Monitoring if Treatment Initiated:

  • Testosterone levels at 3-6 months, targeting mid-normal range 3
  • Hematocrit at 3-6 months and annually (stop if >54%) 10, 3
  • PSA and digital rectal exam at baseline and 3-12 months for men ≥40 years 10, 3
  • Symptom assessment at 3-6 months and annually 3

The bottom line: A testosterone of 212 ng/dL is unequivocally low and concerning, particularly given the mortality associations at this level. Confirm with repeat testing, identify the underlying cause, assess for symptoms, and strongly consider testosterone replacement therapy if symptomatic.

References

Guideline

testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2018

Research

Longitudinal Changes in Sex Hormones in a Population of Older Community-dwelling Men.

The Journal of clinical endocrinology and metabolism, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.